{"transactions":[{"id":768916,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-21T21:21:12.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":1770,"price":56.49,"value":99987.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $56.49 to $56.5009, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1770,"source":{"system":"sec-edgar","filing":"0001225208-26-005548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826005548/doc4.xml","form_type":"4"}},{"id":785628,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2026-05-11T20:32:14.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":1281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Deferred stock units were granted in lieu of 50% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $72,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000 and committee chair retainer having a value of $20,000) divided by the closing price of the common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Deferred stock units were granted in lieu of 50% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $72,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000 and committee chair retainer having a value of $20,000) divided by the closing price of the common stock on the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Deferred stock units were granted in lieu of 50% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $72,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000 and committee chair retainer having a value of $20,000) divided by the closing price of the common stock on the date of grant."}],"balance_after":10998,"derivative":{"underlying":"Common Stock","underlying_shares":1281},"source":{"system":"sec-edgar","filing":"0001225208-26-005111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826005111/doc4.xml","form_type":"4"}},{"id":785627,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2026-05-11T20:32:14.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects a value of $215,000 divided by the closing price of common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan."}],"balance_after":9717,"derivative":{"underlying":"Common Stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001225208-26-005111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826005111/doc4.xml","form_type":"4"}},{"id":863379,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2026-03-05T00:35:31.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":24,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Deferred stock units granted in lieu of 50% yearly cash compensation, vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $1,845.25, divided by the closing price of the common stock on the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Deferred stock units granted in lieu of 50% yearly cash compensation, vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $1,845.25, divided by the closing price of the common stock on the date of grant."}],"balance_after":5917,"derivative":{"underlying":"Common Stock","underlying_shares":24},"source":{"system":"sec-edgar","filing":"0001225208-26-003180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826003180/doc4.xml","form_type":"4"}},{"id":1005949,"issuer":{"id":4001,"kind":"organization","name":"Concentra Group Holdings Parent, Inc."},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-06T22:22:12.000Z","date":"2025-11-04","kind":"grant","planned":false,"acquired":true,"shares":7748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock which, subject to certain exceptions, will vest in full on November 4, 2026, the first anniversary of the grant date."}],"balance_after":20740,"source":{"system":"sec-edgar","filing":"0001104659-25-107876","document":"tm2530505-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014596/000110465925107876/tm2530505-3_4seq1.xml","form_type":"4"}},{"id":1154437,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2025-05-09T21:34:39.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Deferred stock units were granted in lieu of 50% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $62,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Deferred stock units were granted in lieu of 50% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $62,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Deferred stock units were granted in lieu of 50% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $62,500 (representing 50% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant."}],"balance_after":5893,"derivative":{"underlying":"Common Stock","underlying_shares":605},"source":{"system":"sec-edgar","filing":"0001225208-25-004933","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825004933/doc4.xml","form_type":"4"}},{"id":1154436,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2025-05-09T21:34:39.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":2081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects a value of $215,000 divided by the closing price of common stock on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan."}],"balance_after":5288,"derivative":{"underlying":"Common Stock","underlying_shares":2081},"source":{"system":"sec-edgar","filing":"0001225208-25-004933","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825004933/doc4.xml","form_type":"4"}},{"id":1348415,"issuer":{"id":4001,"kind":"organization","name":"Concentra Group Holdings Parent, Inc."},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-29T22:31:09.000Z","date":"2024-11-26","kind":"grant","planned":false,"acquired":true,"shares":6496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Grant of restricted stock which, subject to certain exceptions, will vest in full on November 26, 2025, the first anniversary of the grant date."}],"balance_after":12992,"source":{"system":"sec-edgar","filing":"0001415889-24-027938","document":"form4-11292024_101105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2014596/000141588924027938/form4-11292024_101105.xml","form_type":"4"}},{"id":1348414,"issuer":{"id":4001,"kind":"organization","name":"Concentra Group Holdings Parent, Inc."},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-29T22:31:09.000Z","date":"2024-11-26","kind":"grant","planned":false,"acquired":true,"shares":6496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock which will vest in equal annual installments over five years."}],"balance_after":6496,"source":{"system":"sec-edgar","filing":"0001415889-24-027938","document":"form4-11292024_101105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014596/000141588924027938/form4-11292024_101105.xml","form_type":"4"}},{"id":1493693,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2024-06-04T20:29:01.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Grant of deferred stock units in lieu of 25% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2025 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $30,737.50 (representing 25% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of deferred stock units in lieu of 25% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2025 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $30,737.50 (representing 25% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Grant of deferred stock units in lieu of 25% yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2025 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $30,737.50 (representing 25% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan."}],"balance_after":3207,"derivative":{"underlying":"Common Stock","underlying_shares":407},"source":{"system":"sec-edgar","filing":"0001225208-24-006566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006566/doc4.xml","form_type":"4"}},{"id":1493692,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2024-06-04T20:29:01.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2025 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $211,474 (representing 100% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2025 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $211,474 (representing 100% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2025 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $211,474 (representing 100% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of the common stock on the date of grant. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan."}],"balance_after":2800,"derivative":{"underlying":"Common Stock","underlying_shares":2800},"source":{"system":"sec-edgar","filing":"0001225208-24-006566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824006566/doc4.xml","form_type":"4"}},{"id":2636126,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-12T20:28:24.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":2605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) July 8, 2022, and (ii) the next annual meeting of the Issuer's stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these shares represent RSUs. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":15825,"source":{"system":"sec-edgar","filing":"0001562180-21-004892","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572448/000156218021004892/primarydocument.xml","form_type":"4"}},{"id":2695123,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T20:24:36.000Z","date":"2021-05-24","kind":"tax_withholding","acquired":false,"shares":3555,"price":45.45,"value":161574.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these shares represent Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":13220,"source":{"system":"sec-edgar","filing":"0001562180-21-003745","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1572448/000156218021003745/primarydocument.xml","form_type":"4"}},{"id":2938194,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-18T22:14:21.000Z","date":"2020-12-16","kind":"exercise","acquired":false,"shares":20764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"50% of this option vested and became exercisable on May 23, 2020, with the remainder vesting in three substantially equal installments thereafter."}],"balance_after":21332,"derivative":{"exercise_price":11.89,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":20764},"source":{"system":"sec-edgar","filing":"0000899243-20-034496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924320034496/doc4.xml","form_type":"4"}},{"id":2938193,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T22:14:21.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":8415,"price":56.1488,"value":472492.152,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.80 to $56.655 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"A portion of these shares represent Restricted Stock Units (\"RSUs\"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":16775,"source":{"system":"sec-edgar","filing":"0000899243-20-034496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924320034496/doc4.xml","form_type":"4"}},{"id":2938192,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T22:14:21.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":22732,"price":55.8283,"value":1269088.9156,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.75 to $56.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"A portion of these shares represent Restricted Stock Units (\"RSUs\"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":25190,"source":{"system":"sec-edgar","filing":"0000899243-20-034496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924320034496/doc4.xml","form_type":"4"}},{"id":2938191,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T22:14:21.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":20764,"price":11.89,"value":246883.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"A portion of these shares represent Restricted Stock Units (\"RSUs\"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":47922,"source":{"system":"sec-edgar","filing":"0000899243-20-034496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924320034496/doc4.xml","form_type":"4"}},{"id":3079019,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T22:48:40.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":6110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\") issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full upon the earlier of (i) July 8, 2021, and (ii) the next annual meeting of the Issuer's stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"A portion of these shares represent RSUs."}],"balance_after":27158,"source":{"system":"sec-edgar","filing":"0000899243-20-019824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924320019824/doc4.xml","form_type":"4"}},{"id":3159935,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-06T20:31:31.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":2672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders."}],"balance_after":9131,"source":{"system":"sec-edgar","filing":"0001437749-20-009607","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774920009607/rdgdoc.xml","form_type":"4"}},{"id":3324132,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-01-03T21:02:21.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":148,"price":67.51,"value":9991.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 31, 2019, the reporting person was granted 148 restricted stock units (\"RSUs\") in lieu of cash compensation of $10,000.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Dr. Pegus' separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 31, 2019, the reporting person was granted 148 restricted stock units (\"RSUs\") in lieu of cash compensation of $10,000.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Dr. Pegus' separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy."}],"balance_after":6459,"source":{"system":"sec-edgar","filing":"0001437749-20-000148","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774920000148/rdgdoc.xml","form_type":"4"}},{"id":3337107,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-18T21:23:08.000Z","date":"2019-12-17","kind":"sale","acquired":false,"shares":500000,"price":24.479,"value":12239500.0,"ownership":{"direct":false,"nature":"By Echo Health Ventures LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold in a firm commitment underwritten public offering pursuant to an underwriting agreement dated as of December 12, 2019 by and among the Issuer, the several underwriters and the selling stockholders identified therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Echo Health Ventures LLC. Echo Health Ventures LLC is a joint venture between Cascadia Echo Holdings Company, LLC and Mosaic Health Solutions, LLC. Cascadia Echo Holdings LLC is a subsidiary of Cambia Health Solutions, LLC. The reporting person is the Chief Medical Officer and Senior Vice President of Cambia Health Solutions, LLC. The Reporting Person disclaims beneficial ownership over such shares, except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose."}],"balance_after":1681439,"source":{"system":"sec-edgar","filing":"0000899243-19-029544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924319029544/doc4.xml","form_type":"4"}},{"id":3401544,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-10-02T20:05:40.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":236,"price":42.32,"value":9987.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 30, 2019, the reporting person was granted 236 restricted stock units (\"RSUs\") in lieu of cash compensation of $10,000.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Dr. Pegus' separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 30, 2019, the reporting person was granted 236 restricted stock units (\"RSUs\") in lieu of cash compensation of $10,000.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Dr. Pegus' separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy."}],"balance_after":6311,"source":{"system":"sec-edgar","filing":"0001437749-19-019478","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774919019478/rdgdoc.xml","form_type":"4"}},{"id":3456819,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Senior B Preferred Stock","published_at":"2019-07-24T20:15:34.000Z","date":"2019-07-22","kind":"exercise","acquired":false,"shares":5410084,"ownership":{"direct":false,"nature":"By Echo Health Ventures LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Echo Health Ventures LLC. Echo Health Ventures LLC is a joint venture between Cascadia Echo Holdings Company, LLC and Mosaic Health Solutions, LLC. Cascadia Echo Holdings LLC is a subsidiary of Cambia Health Solutions, LLC. The reporting person is the Chief Medical Officer and Senior Vice President of Cambia Health Solutions, LLC. The reporting person disclaims beneficial ownership over such shares, except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2462128},"source":{"system":"sec-edgar","filing":"0000899243-19-020228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924319020228/doc4.xml","form_type":"4"}},{"id":3456818,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T20:15:34.000Z","date":"2019-07-22","kind":"sale","acquired":false,"shares":280689,"price":18,"value":5052402.0,"ownership":{"direct":false,"nature":"By Echo Health Ventures LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Echo Health Ventures LLC. Echo Health Ventures LLC is a joint venture between Cascadia Echo Holdings Company, LLC and Mosaic Health Solutions, LLC. Cascadia Echo Holdings LLC is a subsidiary of Cambia Health Solutions, LLC. The reporting person is the Chief Medical Officer and Senior Vice President of Cambia Health Solutions, LLC. The reporting person disclaims beneficial ownership over such shares, except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares."}],"balance_after":2181439,"source":{"system":"sec-edgar","filing":"0000899243-19-020228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924319020228/doc4.xml","form_type":"4"}},{"id":3456817,"issuer":{"id":2606,"kind":"organization","name":"Phreesia, Inc.","symbol":"PHR"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-24T20:15:34.000Z","date":"2019-07-22","kind":"exercise","acquired":true,"shares":2462128,"ownership":{"direct":false,"nature":"By Echo Health Ventures LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by Echo Health Ventures LLC. Echo Health Ventures LLC is a joint venture between Cascadia Echo Holdings Company, LLC and Mosaic Health Solutions, LLC. Cascadia Echo Holdings LLC is a subsidiary of Cambia Health Solutions, LLC. The reporting person is the Chief Medical Officer and Senior Vice President of Cambia Health Solutions, LLC. The reporting person disclaims beneficial ownership over such shares, except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares."}],"balance_after":2462128,"source":{"system":"sec-edgar","filing":"0000899243-19-020228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412408/000089924319020228/doc4.xml","form_type":"4"}},{"id":3472085,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-07-02T20:28:10.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":175,"price":56.92,"value":9961.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 28, 2019, the reporting person was granted 175 restricted stock units (\"RSUs\") in lieu of cash compensation of $10,000.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Dr. Pegus' separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 28, 2019, the reporting person was granted 175 restricted stock units (\"RSUs\") in lieu of cash compensation of $10,000.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Dr. Pegus' separation from service from the Company's Board of Directors or a Change in Control as defined in the Policy."}],"balance_after":6075,"source":{"system":"sec-edgar","filing":"0001437749-19-013358","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774919013358/rdgdoc.xml","form_type":"4"}},{"id":3530265,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-13T20:56:59.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders."}],"balance_after":5900,"source":{"system":"sec-edgar","filing":"0001437749-19-009683","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774919009683/rdgdoc.xml","form_type":"4"}},{"id":3569590,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-04-02T20:16:12.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":189,"price":52.72,"value":9964.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 29, 2019, the reporting person was granted 189 restricted stock units (\"RSUs\") in lieu of cash compensation of $10,000.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Dr. Pegus' separation from service from the Company's Board of Directors or a Change in Control as defined in the Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 29, 2019, the reporting person was granted 189 restricted stock units (\"RSUs\") in lieu of cash compensation of $10,000.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and will be settled in Company's common stock upon the earlier of Dr. Pegus' separation from service from the Company's Board of Directors or a Change in Control as defined in the Plan."}],"balance_after":3746,"source":{"system":"sec-edgar","filing":"0001437749-19-006396","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774919006396/rdgdoc.xml","form_type":"4"}},{"id":3935380,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2018-05-14T21:53:04.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":3713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders."}],"balance_after":3713,"derivative":{"exercise_price":45.52,"expiration_date":"2025-05-10","underlying":"Common Stock","underlying_shares":3713},"source":{"system":"sec-edgar","filing":"0001437749-18-009812","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774918009812/rdgdoc.xml","form_type":"4"}},{"id":3935379,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-14T21:53:04.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":1373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders."}],"balance_after":3557,"source":{"system":"sec-edgar","filing":"0001437749-18-009812","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774918009812/rdgdoc.xml","form_type":"4"}},{"id":3958861,"issuer":{"id":167360,"kind":"organization","name":"COGENTIX MEDICAL INC /DE/","symbol":"CGNT"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-23T17:09:49.000Z","date":"2018-04-20","kind":"other","acquired":false,"shares":197472,"price":3.85,"value":760267.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 20, 2018, these shares were purchased in a tender offer for all of the issued and outstanding shares of common stock, par value $0.01 per share, of Cogentix Medical, Inc. (the Company\") by Camden Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of LM US Parent, Inc. and Laborie Medical Technologies Canada ULC, pursuant to the Agreement and Plan of Merger dated as of March 11, 2018 (the \"Merger Agreement\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-18-007492","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894237/000143774918007492/rdgdoc.xml","form_type":"4"}},{"id":4132077,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-14T22:42:52.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":1000,"price":27.86,"value":27860.0,"ownership":{"direct":true},"balance_after":2184,"source":{"system":"sec-edgar","filing":"0001437749-17-020708","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774917020708/rdgdoc.xml","form_type":"4"}},{"id":4236816,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2017-08-11T21:18:47.000Z","date":"2017-08-09","kind":"grant","acquired":true,"shares":3311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Options will vest in full on the earlier of one year after the date of grant or the date of the next year's annual meeting of stockholders, provided the director remains a member of the board as of the vesting date."}],"balance_after":3311,"derivative":{"exercise_price":32.97,"expiration_date":"2024-08-09","underlying":"Common Stock","underlying_shares":3311},"source":{"system":"sec-edgar","filing":"0001437749-17-014559","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774917014559/rdgdoc.xml","form_type":"4"}},{"id":4236815,"issuer":{"id":5451,"kind":"organization","name":"TACTILE SYSTEMS TECHNOLOGY INC"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-08-11T21:18:47.000Z","date":"2017-08-09","kind":"grant","acquired":true,"shares":1184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (RSUs) will vest in full on the earlier of one year after the date of grant or the date of the next year's annual meeting of stockholders, provided the director remains a member of the board as of the vesting date.  RSUs will settle in shares no later than March 15 of the calendar year following the date of vesting."}],"balance_after":1184,"source":{"system":"sec-edgar","filing":"0001437749-17-014559","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027838/000143774917014559/rdgdoc.xml","form_type":"4"}},{"id":4307097,"issuer":{"id":167360,"kind":"organization","name":"COGENTIX MEDICAL INC /DE/","symbol":"CGNT"},"owners":[{"id":45435,"kind":"person","name":"Pegus Cheryl","position":1,"cik":"0001572448","reported_name":"Pegus Cheryl","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-24T17:16:48.000Z","date":"2017-05-23","kind":"grant","acquired":true,"shares":59172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Restricted Stock Award vests in full six months from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total holdings include restricted stock awards."}],"balance_after":197472,"source":{"system":"sec-edgar","filing":"0001437749-17-009998","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894237/000143774917009998/rdgdoc.xml","form_type":"4"}}]}